Metabolic Disease Module Identification

A special issue of Metabolites (ISSN 2218-1989). This special issue belongs to the section "Bioinformatics and Data Analysis".

Deadline for manuscript submissions: closed (15 August 2023) | Viewed by 4948

Special Issue Editors


E-Mail Website
Guest Editor
Institute for Computational Systems Biology, University of Hamburg, D-22607 Hamburg, Germany
Interests: bioinformatics; computational biology; systems medicine; network medicine; metabolomics; multi-omics integration
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
LipiTUM, Technical University of Munich, Munich, Germany
Interests: computational biology; bioinformatics; AI; mass spectrometry; lipidomics; metabolomics; biochemistry; systems biology and medicine; data integration and mining
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Today, societies around the globe are confronted with a steadily increasing occurrence of metabolic disorders such as cardiovascular diseases, obesity, diabetes, fatty liver diseases, and other manifestations of metabolic syndrome. In general, metabolomics research, particularly regarding lipidomics and foodomics, has contributed to crucial links between the host metabolism, disorders and diseases, and lifestyle, including diet choices and activity. Novel bioinformatics and computational biology methodology have been key in identifying these links by integrated analyses in multi-omics settings. However, a large gap has developed between computational solutions for genomics, transcriptomics, and proteomics on the one hand and metabolomics on the other. For the former, experimental and computational methods have been harmonized and consolidated, and community standards have been established. Additionally, publicly accessible web-based services and analysis platforms are broadly available. This is not yet the case for the latter.

One powerful tool to integrate and mine heterogeneous data sources are biological networks. Protein–protein interactions (PPIs) have been successfully used to identify cohort- or sample-specific alterations in gene regulation. Network algorithms, such as local searches or ant colony optimization, have been developed to discover disease-related active modules and subnetworks that are consistently dysregulated in case observations. Via gene set enrichment (GSE) and pathway mapping, these disease modules could be linked to downstream events involved in phenotype expression. These kinds of solutions for computational data integration and mining barely exist for metabolic or biochemical reaction networks.

Therefore, this Special Issue aims to highlight state-of-the-art computational methods that 1.) identify active modules in metabolic and/or biochemical reaction as well as heterogeneous (hyper-)networks and 2.) that are capable of mechanistically linking these modules to upstream alterations on a protein, transcript, and gene level. Hence, this Special Issue focuses on the demonstration and application of innovative computational approaches in the fields of metabolomics, including closely related fields such as lipidomics and foodomics, etc., as well as biochemistry and biophysics. These methods should lead to insights into molecular disease mechanisms, marker, and drug identification, options for treatment and therapy, and molecular stratification and disease classification. Methods may include and combine statistical analyses, biological network analyses and network biomedicine, pathway analyses and computational models, machine learning and AI, and big data analyses. Integrated multi-omics approaches with a strong contribution to filling the previously described gap in metabolomics are highly encouraged. Manuscripts will be reviewed accordingly, considering their innovative value in creating solutions to the described current problems. All methods should be easily applicable to researchers of all involved disciplines.

Prof. Dr. Jan Baumbach
Dr. Josch K. Pauling
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • metabolomics
  • systems medicine
  • disease mechanisms
  • bioinformatics
  • multi-omics

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 5133 KiB  
Article
The Combination of Bioinformatics Analysis and Untargeted Metabolomics Reveals Potential Biomarkers and Key Metabolic Pathways in Asthma
by Fangfang Huang, Jinjin Yu, Tianwen Lai, Lianxiang Luo and Weizhen Zhang
Metabolites 2023, 13(1), 25; https://doi.org/10.3390/metabo13010025 - 23 Dec 2022
Cited by 4 | Viewed by 2119
Abstract
Asthma is a complex chronic airway inflammatory disease that seriously impacts patients’ quality of life. As a novel approach to exploring the pathogenesis of diseases, metabolomics provides the potential to identify biomarkers of asthma host susceptibility and elucidate biological pathways. The aim of [...] Read more.
Asthma is a complex chronic airway inflammatory disease that seriously impacts patients’ quality of life. As a novel approach to exploring the pathogenesis of diseases, metabolomics provides the potential to identify biomarkers of asthma host susceptibility and elucidate biological pathways. The aim of this study was to screen potential biomarkers and biological pathways so as to provide possible pharmacological therapeutic targets for asthma. In the present study, we merged the differentially expressed genes (DEGs) of asthma in the GEO database with the metabolic genes obtained by Genecard for bioinformatics analysis and successfully screened out the metabolism-related hub genes (HIF1A, OCRL, NNMT, and PER1). Then, untargeted metabolic techniques were utilized to reveal HDM-induced metabolite alterations in 16HBE cells. A total of 45 significant differential metabolites and 5 differential metabolic pathways between the control group and HDM group were identified based on the OPLS-DA model. Finally, three key metabolic pathways, including glycerophospholipid metabolism, galactose metabolism, and alanine, aspartate, and glutamate metabolism, were screened through the integrated analysis of bioinformatics data and untargeted metabolomics data. Taken together, these findings provide valuable insights into the pathophysiology and targeted therapy of asthma and lay a foundation for further research. Full article
(This article belongs to the Special Issue Metabolic Disease Module Identification)
Show Figures

Graphical abstract

17 pages, 17754 KiB  
Article
Bariatric Surgery Associates with Nonalcoholic Steatohepatitis/Hepatocellular Carcinoma Amelioration via SPP1 Suppression
by Shuai Chen, Liming Tang, Adrien Guillot and Hanyang Liu
Metabolites 2023, 13(1), 11; https://doi.org/10.3390/metabo13010011 - 21 Dec 2022
Cited by 2 | Viewed by 1646
Abstract
Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases worldwide and no effective drugs or treatments have been approved for disease management. Recently, bariatric surgery (BS) is considered to be a novel disease-modifying therapy for NASH and liver metabolic diseases, [...] Read more.
Nonalcoholic steatohepatitis (NASH) is one of the most common chronic liver diseases worldwide and no effective drugs or treatments have been approved for disease management. Recently, bariatric surgery (BS) is considered to be a novel disease-modifying therapy for NASH and liver metabolic diseases, according to clinical follow-up studies. Despite the revealment of physiopathological alterations, underlying mechanisms and key factors remain indeterminate. This study included multiple bulk RNA-sequencing datasets to investigate transcriptome variation in one-year follow-up BS and diet management (Diet) NASH patients’ liver biopsies. Liver functions, fibrosis, and carcinogenesis were predicted in liver samples via hallmark-based function enrichment analysis. Key factors generated from multi-dataset comparison were further assessed with hepatocellular carcinoma (HCC) progression and prognosis. BS leads to active gene expression alterations in NASH liver in comparison to diet management (Diet). Both approaches reduce cell stress and immune response, whereas BS contributes to higher metabolic levels and lower apoptosis levels. The macrophage infiltration, adipose accumulation, and fibroblast activation were revealed to be lower in post-BS NASH livers, further demonstrating positive correlations mutually. Seven key genes (MNDA, ALOX5AP, PECAM1, SPP1, CD86, FGF21, CSTA) were screened out as potential macrophage-associated and carcinogenetic factors suppressed by BS. SPP1 was identified as a crucial factor participating in BS intervened NASH-HCC progression. This study determined that BS exerts potentially superior protective functions in NASH livers compared to diet management. SPP1 may serve as a novel factor to study the functionalities of BS on NASH patients. Full article
(This article belongs to the Special Issue Metabolic Disease Module Identification)
Show Figures

Figure 1

Back to TopTop